Independent Director's Annual Work Report for 2025
As the independent director of Nanjing Quanxin Transmission Technology Co., Ltd. (hereinafter referred to as "the Company"), I, Xu Min, have diligently fulfilled my responsibilities in accordance with the Company Law, Securities Law, and relevant regulations, as well as the Company's Articles of Association and the Independent Director System. I have attended meetings punctually, conducted thorough investigations on important matters, and provided opinions on significant issues, effectively playing my role as an independent director and a member of various professional committees.
1. Basic Information of the Independent Director
Xu Min, male, Chinese nationality, no foreign residency, born in 1964, a member of the Communist Party of China, holds a doctoral degree, is a level-three professor, and a master's supervisor. He is currently the director of the "Collaborative Innovation and Industrial Development Research Center" at Nanjing University of Technology, an executive director of the Higher Engineering Colleges Branch of the Chinese Accounting Society, and a member of the editorial board of the Journal of Nanjing University of Technology (Social Sciences Edition). His main research focuses on corporate financial theory and practice, technological innovation, and evaluation. He is currently an independent director of the Company, Jiangsu Kangyuan Pharmaceutical Co., Ltd., and Jiangsu Southern Weichai Pharmaceutical Co., Ltd. His professional background is in finance, and he does not manage the Company's specific business operations. During the reporting period, I met the independence requirements stipulated in Article 6 of the Administrative Measures for Independent Directors of Listed Companies, with no factors affecting my independence.
2. Performance in 2025
(1) Attendance at Board and Shareholder Meetings
In 2025, the Company's board of directors held a total of 7 meetings. My attendance as an independent director is as follows:
| Independent Director Name | Required Attendance | In-Person Attendance | Attendance by Communication | Proxy Attendance | Absences | Consecutive Absences | Attendance at Shareholder Meetings |
|---|---|---|---|---|---|---|---|
| Xu Min | 7 | 2 | 4 | 1 | 0 | No | 3 |
This year, I attended board meetings on time and participated in shareholder meetings, with no instances of consecutive absences. I carefully reviewed all proposals presented at the board and shareholder meetings and provided suggestions on execution issues, exercising my voting rights independently, objectively, and prudently. I believe that the convening of the board and shareholder meetings complied with legal procedures, and all significant operational matters followed the relevant approval processes, being legal and effective.
(2) Performance in Various Board Committees
During the reporting period, I served as the chairman of the Audit Committee, a member of the Nomination Committee, and a member of the Compensation and Assessment Committee of the seventh board. I strictly adhered to the Company Law, Articles of Association, and the rules of each committee, leveraging my financial expertise to actively fulfill my duties, provide timely suggestions, and promote the effective functioning of each committee. As the chairman of the Audit Committee, I conducted work in accordance with relevant laws, regulations, and the Company's internal policies. During the reporting period, I participated in six Audit Committee meetings, reviewed the implementation of the Company's internal control systems, regularly monitored the Company's financial and operational status, and audited the annual reports, quarterly reports, and interim reports, continuously focusing on the use of raised funds and fulfilling my responsibilities as a committee member.